缺氧培养的脂肪间充质干细胞减少软骨损伤。
Adipose Derived Mesenchymal Stem Cells from a Hypoxic Culture Reduce Cartilage Damage.
机构信息
School of Medicine, Department of Surgery, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Department of Orthopaedics & Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan.
出版信息
Stem Cell Rev Rep. 2021 Oct;17(5):1796-1809. doi: 10.1007/s12015-021-10169-z. Epub 2021 Apr 24.
The method to benifit tissue engineering of adipose-derived stem cells (ADSCs) to cartilage has been an objective of intense research in treating increasing cartilage-related disease. In this study, whether hypoxic expansion would enhance the proliferation and in vitro chondrogenic differentiation of ADSCs was studied, and then hypoxic expansion was applied to reduce cartilage damage in a rat model in vivo. Hypoxic expansion increased the proliferation and decreased the expression of aging-related genes, including p16, p21, and p53, of human ADSCs in comparison with normoxic expansion. In addition, the γH2AX expression was reduced in the hypoxic ADSCs. The chondrogenic markers were enhanced in the hypoxic ADSC differentiated chondrogenic pellets, including SOX9 on day 7 and gene expressions of COL 2 and COL 10 on day 21. To determine the in vitro chondrogenic differentiation potential of ADSCs, ADSC differentiated 21-day chondrogenic pellets were stained by Alcian blue staining and the immunostaining of COL 2 and COL 10, the results of which confirmed the enhancement of differentiation potential after the hypoxic expansion. Moreover, cartilage injury in a rat model was reduced by hypoxic ADSC treatment that was determined by histological and immunohistochemical staining detections. The effects of hypoxic expansion of ADSCs and bone marrow-derived stem cells (BMSCs) on chondrogenic differentiation potential were also compared. Smaller sizes were presented in the in vitro hypoxic BMSC differentiated chondrogenic pellets, whereas the chondrogenic marker expressions were significantly higher than those of the hypoxic ADSCs. However, there was no significant difference between the treatments of the hypoxic ADSCs and BMSCs in the cartilage injury in vivo. In conclusion, hypoxic expansion increases the chondrogenic differentiation potential of ADSCs and BMSCs in vitro and enhances them to reduce cartilage damage in vivo. Although the hypoxic BMSCs showed compact chondrogenic pellet formation and higher potential of chondrogenesis, the easy access and large resources of ADSCs still uplifted the application.
将脂肪来源干细胞(ADSCs)用于软骨组织工程的方法一直是治疗日益增多的软骨相关疾病的研究热点。本研究旨在探讨低氧扩增是否能增强 ADSC 的增殖能力和体外软骨分化能力,并将低氧扩增应用于体内减少软骨损伤的大鼠模型。与常氧扩增相比,低氧扩增增加了人 ADSC 的增殖能力,降低了衰老相关基因(包括 p16、p21 和 p53)的表达。此外,低氧 ADSC 中的γH2AX 表达减少。低氧 ADSC 分化的软骨形成小珠中的软骨形成标志物增强,包括第 7 天的 SOX9 和第 21 天的 COL2 和 COL10 的基因表达。为了确定 ADSC 的体外软骨分化潜能,用茜素红 S 染色和 COL2 和 COL10 的免疫染色对 21 天分化的软骨形成小珠进行染色,结果证实低氧扩增后分化潜能增强。此外,通过组织学和免疫组织化学染色检测,低氧 ADSC 处理可减少大鼠模型中的软骨损伤。还比较了低氧扩增的 ADSC 和骨髓来源干细胞(BMSCs)对软骨分化潜能的影响。体外低氧 BMSC 分化的软骨形成小珠体积较小,而软骨形成标志物的表达明显高于低氧 ADSC。然而,在体内软骨损伤方面,低氧 ADSC 和 BMSC 的治疗无显著差异。总之,低氧扩增可增加 ADSC 和 BMSC 的体外软骨分化潜能,并增强其在体内减少软骨损伤的作用。虽然低氧 BMSCs 显示出更紧凑的软骨形成小珠形成和更高的软骨生成潜力,但 ADSC 易于获得且资源丰富,仍具有应用价值。